Aim. -The prevalence and risk factors associated with symptoms of anxiety and depression were determined in African people with diabetes.
Introduction
According to the World Health Organization, we are facing an epidemic of diabetes in the developing countries. Currently, over 80% of people with diabetes live in low-and middleincome countries (LMICs) [1] . This clinical situation also refers to Guinea, where the age-standardized prevalence of diabetes according to the Guinean census was 6.5% (95% CI: 5.3-7.7%) [2] .
Epidemiological data on the characteristics of T2D patients most affected by anxiety/depression in LMICs remain sparse, yet are essential for implementing public-health programmes in these countries [8] . The goal of the present study was to assess the prevalence of both anxiety and depression in people with T2D in Guinea and to identify the factors associated. Furthermore, the study examined whether the association between psychological distress and diabetes is affected by level of glycaemic control in such people from a low-income country with limited access to regular healthcare.
Materials and methods

Study setting and design
This cross-sectional multicentre study was conducted at four health institutions in Guinea: the Endocrinology, Diabetology and Metabolic Disease Unit of the University Teaching Hospital (UTH) of Conakry, and the diabetes units of regional hospitals at Boké, Kankan and Labé.
Population
Between August 2009 and October 2010, a study to improve glycated haemoglobin (HbA 1c ) in diabetic patients was carried out in Cameroon and Guinea. The study included patients aged ≥ 16 years with T2D for at least 12 months. They were contacted at the outpatients clinic of the four study sites and invited to participate in the study. Patients who had lost a family member (parent, brother, sister, husband, children) and/or their job in the month preceding the study were excluded from the study. In total, 491 patients with T2D were included in the study.
Methods
A semi-structured questionnaire and a standardized interview were completed for all participants. Data on socioeconomic status (SES), history of diabetes, and levels of anxiety and depression were collected.
Sociodemographic profiles
The sociodemographic data collected included age, gender, zone of residence (rural or urban), marital status (single or married) and unemployment status (yes or no). Level of education was divided into two classes (< 7 years of school and ≥ 7 years of school). SES was assessed from unemployment status and level of education, and dichotomized into low (lower level of education and unemployment) or high (higher education or/and employment).
History of diabetes and clinical data
Other information collected included type of glucoselowering treatment, duration of diabetes and previous measurement of HbA 1c (yes or no). HbA 1c was classified into < 7.0%, 7.0-8.9% and ≥ 9.0%.
The clinical data collected included current tobacco smoking (yes or no) and known hypertension (yes or no). Alcohol consumption during the previous month was self-reported. Body mass index (BMI) was calculated.
Level of anxiety and depression
Symptoms of anxiety and depression were evaluated using the Hospital Anxiety and Depression Scale (HADS) [9] . The French version used in our study had previously been validated in both family medicine and hospital settings [10] . The HADS measures levels of symptoms during the past week. There is a medium-to-strong correlation between the HADS score and other instruments used to measure anxiety and depression, including the Beck Depression Inventory, the Spielberger State-Trait Anxiety Inventory, the Symptom Checklist-90 Scale and the Montgomery-Asberg Depression Rating Scale [11] . The main characteristic of HADS is that items that could be attributed to physical illnesses, such as insomnia, fatigue, headaches, dizziness, sleep and appetite disturbance, have been omitted to avoid false-positive cases among individuals with somatic diseases. HADS has 14 questions: seven are related to depression (HADS-D), and seven to anxiety (HADS-A). Each question has four possible responses on a scale of 0 (no symptoms) to 3 (maximum symptoms). Severity of symptoms is determined by the total score obtained for each subscale (HADS-A and HADS-D), and is classified as normal (0-7), mild disorder (8-10) and marked disorder (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) . HADS-D covers mainly anhedonia and loss of interest, which are core depressive symptoms, while HADS-A covers the core anxiety features of worry and tenseness.
Ethical considerations
The ethics committee of the Ministry of Public Health of Guinea approved the study. Only patients who signed the informed consent form were included in the study.
Statistical analysis
The prevalence of symptoms of anxiety and depression was determined using the HADS and classified as normal, or mild or marked disorder. For the logistic regression analysis, the HADS scores were dichotomized as normal (score 0-7) or the presence of anxiety/depression (score 8-21) to include all possible cases of anxiety and depression, as suggested by Zigmond and Snaith [9] . Univariate logistic regression analyses evaluated the relationships between anxiety and depression and the associated factors, and the results are presented as odd ratios (OR) and 95% confidence intervals (CI). As interactions were tested by gender and revealed a significant interaction for some variables, all results are presented stratified by gender. Variables with P values < 0.20 in the univariate tests were selected as covariates for the multivariable models. A P value < 0.05 was considered statistically significant. All analyses used SAS version 9.3 software (SAS Institute, Cary, NC, USA). 
Results
General patients' description
General characteristics of the 491 patients with T2D included in this study are presented in Table 1 . The majority were female (62.7%), married (76.4%), employed (54.2%) and had high levels of education (50.5%). No patient was being treated with antidepressant drugs. Mean age was 57.9 ± 10.2 years, and the men were older (59.8 ± 9.7 years) than the women (56.7 ± 10.3 years). Only 6.7% of patients had a previous measurement of HbA 1c . Out of all the study patients, 15.7% had good glycaemic control (HbA 1c < 7.0%), and 29.1% (n = 143) were being treated with insulin, with the remainder taking oral glucose-lowering drugs.
Prevalence of anxiety and depression
On the HADS, a mean score of 8.5 ± 3.2 and a median of 8 for anxiety were recorded. For depression, the mean score was 6.3 ± 3.3 with a median of 6. Table 2 presents the prevalence of anxiety and depression as classified by the HADS according to gender. Symptoms of anxiety were present in 58.7% of patients, while 34.4% had symptoms of depression. The prevalence of marked anxiety was 27.5%, and was more common in women (36.1%) than in men (13.1%). Marked depression was present in 11.4% of the population, and again was more common in women (14.0%) than in men (7.1%). Of our 491 diabetic patients, 127 (25.9%) had both anxiety and depression, and neither anxiety nor depression was related to overweight/obese status.
Factors associated with anxiety
As shown in Table 3 
Factors associated with depression
In a multivariate model ( 
Discussion
The present study has shown that both anxiety and depression are commonplace in patients with T2D attending outpatients clinics in Guinea. Also, the prevalence of depression and anxiety in our sample population was higher than previously observed in Caucasian T2D populations [12, 13] . However, a recent largescale cross-sectional multinational study found no association between diabetes and prevalence of depressive symptoms in Africa, in contrast to other continents [14] .
Other studies have reported a higher prevalence of depression with diabetes in developing countries with results similar to ours; for example, in Pakistan, 57.9% had anxiety and 43.5% had depression [15] . In a recent review, the percentage of people with depression among those with diabetes was 45.9% in South Africa, and between 15% and 30% in Nigeria [8] . This high prevalence of anxiety and depression in LMICs such as Guinea could be explained by gender inequality, social insecurity, low educational levels and poverty [16] .
In the present study, it was observed that poor glucose control was independently associated with both anxiety and depression in men. Previous reports have shown a positive association between HbA 1c levels, fasting blood glucose and levels of anxiety [4, 6, 17] . Depressive mood has been also associated with glucose levels in T2D [18] . In a recent study in The Netherlands, several individual depressive symptoms were related to higher HbA 1c levels in outpatients with T2D, and these associations persisted over time [19] . Underlying mechanisms proposed to explain the increase in glycaemia are enhanced inflammation [20] , insulin resistance [21] , alterations in insulin secretion [22] and activation of the hypothalamic-pituitary-adrenal axis [23] . Furthermore, depression and anxiety are also linked with poorer behavioural management of diabetes and glycaemic control [24] . The use of insulin therapy in our study was independently associated with symptoms of depression. This is in agreement with previous reports [25, 26] . Insulin therapy could be associated with negative beliefs about the future and risk of death for the patient. However, the need for insulin therapy often indicates a more severe stage of the disease, which is characterized by age, poorer glycaemic control and a higher rate of complications. Nevertheless, in our study, this association Table 3 Factors associated with symptoms of anxiety (HADS-A score ≥ 8) in outpatients with type 2 diabetes in Guinea. persisted even after adjusting for age and HbA 1c , suggesting that the perceptions that surround insulin therapy itself, irrespective of the metabolic context, could favour the development of depressive symptoms. Only a prospective study with a longitudinal follow-up can adequately test this hypothesis. The lack of previous measurements of HbA 1c was independently associated with the presence of depression in women. A number of studies have shown that depression is associated with poor perceived control of diabetes and poor self-care behaviours [27, 28] . In addition, it may be speculated that a previous measurement of HbA 1c might be an indirect indicator of the patient's participation in a structured diabetes medical programme, which may have contributed to giving more reassurance to the patient, thereby explaining why these patients were less depressed. The lack of information on glycaemia status might also be potentially worrying to the patient. In addition, depression may prevent efforts dedicated to health, resulting in a lower probability of having an HbA 1c measurement. Nevertheless, reverse causality, by which poor glycaemic control may induce greater psychological distress, cannot be excluded.
Anxiety (HADS-
It was observed that age was independently associated with symptoms of depression, whereas duration of diabetes was not an independent risk factor after accounting for age. Findings for the relationship between age and depression in diabetes have been conflicting, with some studies reporting age as a risk factor for depression [15, 29] whereas, in other studies, younger age was related to depressive symptoms [30] .
Our study provides new findings concerning the relationship between socioenvironmental factors and the presence of anxiety/depression in people with T2D in a developing African country. Our results for women showed that those of low SES were twice as likely to be depressed compared with those of high SES. This is in agreement with other studies showing that the risk of depression is higher for diabetic patients with lower SES [29, 31] . In contrast, however, a higher SES was independently found to be associated with symptoms of anxiety. Unemployment is also a consistent risk factor for psychological disorders, suggesting the importance of taking into consideration the presence of depression among patients with diabetes who are unemployed or who have less education, which is common in Africa [32] . It has been shown that depression is more commonly seen among those with low family income, non-professional/administrative employment, no current employment and so are dependent, and those living alone and with less social support [29] . Indeed, it has long been recognized that individuals with lower SES suffer a disproportionate share of the burden and consequences of numerous diseases than those with higher SES [33] .
It was also revealed that an urban area of residence was independently associated with symptoms of both anxiety and depression in women, a relationship that remains controversial in the developing countries. A study in Pakistan showed a greater prevalence of mental disorders in urban areas than in rural areas [34] . In contrast, no significant association between depression comorbidity and place of residence was found in a study from Nigeria [35] .
Our present study has several intrinsic limitations. First, as symptoms of depression and anxiety were only measured at one time point, this study cannot directly evaluate the long-term impact of diabetes on the incidence of anxiety/depression. Thus, the observational nature of the study allows no conclusions to be drawn on the causality of the link between depression and poor glycaemic control. Second, the study population was not randomly sampled, which limits attempts to generalize the results to all populations with T2D in Guinea. Third, the HADS-D score predominantly reflects melancholic depressive symptoms over the past week. Thus, levels of lifetime depression and the proportion of subjects with atypical depressive symptoms might have been underestimated in our cohort. Also, the study may have slightly underestimated the prevalence of anxiety and depression because patients who had lost a family member and/or their job in the month preceding the study were excluded. Finally, it was not possible to adjust for risk factors such as a previous or family history of depression, childhood experiences, life experiences and sickle cell disease. The prevalence of the latter is high in Guinea, and its presence is known to affect measurements of HbA 1c [36] .
Our findings show that people with T2D in Sub-Saharan Africa are at risk of anxiety and depression just as reported in high-income countries [37] . The high prevalence of anxiety and depression in Guinea is an important additional publichealth burden, as the country faces an alarming increase in the prevalence of T2D in Africa [38] .
These findings also suggest that the healthcare infrastructure, which has traditionally focused on infectious diseases in Guinea, needs to evolve to take better account of the psychological burden associated with diabetes, particularly in urban areas. The screening and monitoring of psychological disorders in people with diabetes are still neglected in Africa, and the treatment of diabetes-related depression is rare in these countries, too [39, 40] . Medical-economic studies have shown that the coexistence of depression and diabetes is associated with greater use of healthcare services and medical costs [4] .
In conclusion, our results show that both anxiety and depression are common in people with T2D living in Guinea, irrespective of overweight/obesity status. Poor control of glycaemia, residence in an urban area, no previous measurements of HbA 1c and use of insulin therapy appear to be risk factors for depression in this population. These findings suggest that depression in T2D patients in Africa needs to be screened for and taken into consideration in their medical care.
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